EyePoint Pharmaceuticals Inc banner

EyePoint Pharmaceuticals Inc
NASDAQ:EYPT

Watchlist Manager
EyePoint Pharmaceuticals Inc Logo
EyePoint Pharmaceuticals Inc
NASDAQ:EYPT
Watchlist
Price: 4.348 USD -4.65% Market Closed
Market Cap: $364.5m

Intrinsic Value

The intrinsic value for EyePoint Pharmaceuticals Inc (EYPT) under the Base Case is 1.944 USD. Compared with the current market price of 4.348 USD, the stock appears Overvalued by 55% .

Intrinsic value calculated using Multiples
$1.944
Other reference points

Do our valuations actually work? See backtest results .

EYPT Intrinsic Value
$1.944
Overvaluation 55%
Intrinsic Value
Price $4.348
Monitor EYPT
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $1.56
Get notified when the price drops into your buy zone
Current Price $4.35
Intrinsic Value $1.94
Margin of Safety 20% $1.56
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Ask AI Assistant
What other research platforms think about EYPT?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is EYPT valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for EyePoint Pharmaceuticals Inc.

Explain Valuation
Alternatives to EYPT

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

EYPT Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one EYPT stock?

The intrinsic value for EyePoint Pharmaceuticals Inc (EYPT) under the Base Case is 1.944 USD.

Is EYPT stock undervalued or overvalued?

Compared with the current market price of 4.348 USD, the stock appears Overvalued by 55% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett